Clinical Trials
4 trialsNCT04305145 2026-01-29
Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
Massachusetts General Hospital
Phase 2 Active not recruiting
NCT02814864 2021-08-03
PRISME
Assistance Publique - Hôpitaux de Paris
Phase 2 Unknown
NCT00533078 2015-07-23
LUNCH1
Insel Gruppe AG, University Hospital Bern
Phase 2 Completed
NCT00676832 2010-09-29
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
Prometheus Laboratories
Phase 2 Completed